Follow
Wesley Yin
Title
Cited by
Cited by
Year
Tying Odysseus to the mast: Evidence from a commitment savings product in the Philippines
N Ashraf, D Karlan, W Yin
The Quarterly Journal of Economics 121 (2), 635-672, 2006
20922006
Female empowerment: Impact of a commitment savings product in the Philippines
N Ashraf, D Karlan, W Yin
World development 38 (3), 333-344, 2010
8482010
Poverty alleviation through geographic targeting: How much does disaggregation help?
C Elbers, T Fujii, P Lanjouw, B Özler, W Yin
Journal of Development Economics 83 (1), 198-213, 2007
3112007
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures
W Yin, A Basu, JX Zhang, A Rabbani, DO Meltzer, GC Alexander
Annals of internal medicine 148 (3), 169-177, 2008
2532008
Market incentives and pharmaceutical innovation
W Yin
Journal of Health Economics 27 (4), 1060-1077, 2008
2102008
Deposit collectors
N Ashraf, D Karlan, W Yin
The BE Journal of Economic Analysis & Policy 6 (2), 0000102202153806371483, 2006
1812006
A review of commitment savings products in development countries
N Ashraf, N Gons, DS Karlan, W Yin
ERD working paper series, 2003
1262003
Medical debt in the US, 2009-2020
R Kluender, N Mahoney, F Wong, W Yin
Jama 326 (3), 250-256, 2021
1042021
R&D policy, agency costs and innovation in personalized medicine
W Yin
Journal of health economics 28 (5), 950-962, 2009
762009
The market for high-quality medicine: retail chain entry and drug quality in India
D Bennett, W Yin
Review of Economics and Statistics 101 (1), 76-90, 2019
74*2019
The role of behavioral frictions in health insurance marketplace enrollment and risk: Evidence from a field experiment
R Domurat, I Menashe, W Yin
American Economic Review 111 (5), 1549-1574, 2021
692021
Impact of Medicare Part D on Medicare–Medicaid dual‐eligible beneficiaries' prescription utilization and expenditures
A Basu, W Yin, GC Alexander
Health services research 45 (1), 133-151, 2010
672010
Environmental regulation and industrial performance: Evidence from unexpected externalities in China
GH Jefferson, S Tanaka, W Yin
Available at SSRN 2216220, 2013
652013
Insurers’ negotiating leverage and the external effects of Medicare Part D
D Lakdawalla, W Yin
Review of Economics and Statistics 97 (2), 314-331, 2015
59*2015
Household decision making and savings impacts: further evidence from a commitment savings product in the Philippines
N Ashraf, DS Karlan, W Yin
Yale University Economic Growth Center Discussion Paper, 2006
552006
Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA
D Goldman, D Lakdawalla, TJ Philipson, W Yin
Health Econ 19 (10), 1109-1116, 2010
522010
Economic burden of multiple myeloma among patients in successive lines of therapy in the United States
JP MacEwan, K Batt, W Yin, D Peneva, S Sison, S Vine, C Chen
Leukemia & lymphoma 59 (4), 941-949, 2018
442018
The impact of the Medicare Part D prescription benefit on generic drug use
JX Zhang, W Yin, SX Sun, GC Alexander
Journal of general internal medicine 23, 1673-1678, 2008
442008
Environmental regulation and industrial performance: Evidence from China
S Tanaka, W Yin, GH Jefferson
Work. Pap., Tufts Univ., Medford, MA, 2014
422014
Evaluating cost benefits of combination therapies for advanced melanoma
IS Jensen, E Zacherle, CM Blanchette, J Zhang, W Yin
Drugs in Context 5, 2016
252016
The system can't perform the operation now. Try again later.
Articles 1–20